Moderna, Inc. (MRNA)
Pre-market:
| Previous close | 56.83 |
| Open | 56.71 |
| Bid | 58.27 x 500 |
| Ask | 58.33 x 500 |
| Day's range | 55.70 - 59.73 |
| 52-week range | 55.70 - 170.47 |
| Volume | |
| Avg. volume | 4,769,218 |
| Market cap | 22.406B |
| Beta (5Y monthly) | 1.66 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Bloomberg
CDC Probes If Bird Flu Mutations Impact Vaccine Stockpile
(Bloomberg) -- The Centers for Disease Control and Prevention is investigating whether the US stockpile of bird flu vaccines is still well matched to the virus after discovering recent mutations. Most Read from BloombergDubai’s Allure to Expats Is Weighing on City’s InfrastructureThe Master Plan That Shaped Pakistan’s Capital Is No Longer WorkingThe Cablebus Transformed Commutes in Mexico City’s Populous OutskirtsAs Brussels Booms, an Old Boogeyman Returns: BrusselizationChicago Marathon to Hono
- Investor's Business Daily
Is Moderna Stock A Sell After The Company Slashed Its R&D Budget?
Moderna stock tumbled after the company issued a light 2025 sales outlook and cut its 2027 R&D budget. Is MRNA stock a sell?
- Bloomberg
Covid-Shot Maker Goes Bankrupt After Trailing Pfizer, Moderna
(Bloomberg) -- Gritstone Bio Inc., a vaccine developer that once touted its ability to make a next-generation Covid-19 shot, filed for Chapter 11 bankruptcy in Delaware Thursday. Most Read from BloombergThe Cablebus Transformed Commutes in Mexico City’s Populous OutskirtsSan Francisco to Shut 9% of Public Schools Amid Budget WoesChicago’s $1 Billion Budget Hole Exacerbated by School TurmoilUrban Heat Stress Is Another Disparity in the World’s Most Unequal NationShould Evictions Be Banned After H
